2 results
Approved WMORecruiting
The primary endopoint is to determine whether ketoconazole/octreotide combination therapy, followed by octreotide monotherapy, is an effective treatment for Cushing's disease. Secundary endpoints address the effects of this therapy on boneā¦
Approved WMORecruiting
To assess safety and tolerability of AMX0035 for treatment of ALS.